What is the life expectancy for wild-type ATTR amyloidosis? It's a really important question, and the honest answer is that it varies from person to person.
Studies suggest that the median survival after diagnosis is around 3.5 years, but this number isn't set in stone. Many people live longer, especially with treatment Show Full Answer
What is the life expectancy for wild-type ATTR amyloidosis? It's a really important question, and the honest answer is that it varies from person to person.
Studies suggest that the median survival after diagnosis is around 3.5 years, but this number isn't set in stone. Many people live longer, especially with treatment. Several factors can influence outlook, including:
- Age at diagnosis — older age can affect prognosis
- Heart function — more severe heart involvement tends to mean a harder road
- Biomarkers — certain proteins in the blood that reflect heart health
- Ability to perform daily activities — overall functional health matters
The good news is that wild-type ATTR tends to progress slowly, which generally gives it a more favorable outlook compared to other forms of amyloidosis. Treatments like tafamidis, acoramidis, and vutrisiran can help slow the buildup of amyloid deposits in the heart, which may improve quality of life and survival. In select cases, a heart transplant may also extend life expectancy, though it's typically considered for younger or healthier individuals.
Advances in treatment are continuing to improve outcomes, so staying in close contact with a specialist is really key.
July 23
Join
Your Privacy Choices
